Howard A. Young, Ph.D.

Articles

Final Word: NIH-Biopharm Interactions and the New NIH Conflict-of-Interest Regulations

. . . These new stringent rules will strongly impact the pipeline of scientific talent the NIH has provided the biopharm industry.